1. Home
  2. IPSC vs SPRU Comparison

IPSC vs SPRU Comparison

Compare IPSC & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SPRU
  • Stock Information
  • Founded
  • IPSC 2019
  • SPRU 2008
  • Country
  • IPSC United States
  • SPRU United States
  • Employees
  • IPSC N/A
  • SPRU N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SPRU Auto Parts:O.E.M.
  • Sector
  • IPSC Health Care
  • SPRU Consumer Discretionary
  • Exchange
  • IPSC Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • IPSC 49.1M
  • SPRU 48.7M
  • IPO Year
  • IPSC 2021
  • SPRU N/A
  • Fundamental
  • Price
  • IPSC $0.56
  • SPRU $2.66
  • Analyst Decision
  • IPSC Strong Buy
  • SPRU
  • Analyst Count
  • IPSC 5
  • SPRU 0
  • Target Price
  • IPSC $3.33
  • SPRU N/A
  • AVG Volume (30 Days)
  • IPSC 1.4M
  • SPRU 103.4K
  • Earning Date
  • IPSC 11-07-2025
  • SPRU 11-11-2025
  • Dividend Yield
  • IPSC N/A
  • SPRU N/A
  • EPS Growth
  • IPSC N/A
  • SPRU N/A
  • EPS
  • IPSC N/A
  • SPRU N/A
  • Revenue
  • IPSC $114,128,000.00
  • SPRU $98,396,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • SPRU $2.12
  • Revenue Next Year
  • IPSC N/A
  • SPRU N/A
  • P/E Ratio
  • IPSC N/A
  • SPRU N/A
  • Revenue Growth
  • IPSC 5491.77
  • SPRU 23.43
  • 52 Week Low
  • IPSC $0.34
  • SPRU $1.13
  • 52 Week High
  • IPSC $1.83
  • SPRU $3.41
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 48.92
  • SPRU 49.48
  • Support Level
  • IPSC $0.55
  • SPRU $2.57
  • Resistance Level
  • IPSC $0.65
  • SPRU $3.23
  • Average True Range (ATR)
  • IPSC 0.04
  • SPRU 0.21
  • MACD
  • IPSC -0.00
  • SPRU -0.06
  • Stochastic Oscillator
  • IPSC 18.00
  • SPRU 13.64

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: